Lloye M. Dillon, PhD
Associate Director, Pharmacodiagnostics at Bristol-Myers Squibb
Princeton, NJ
Lloye has over 13 years experience working at the interface of academia and industry and is passionate about cancer awareness and personalized care for cancer patients. She received her Ph.D. degree in Molecular Cell and Developmental Biology from University of Miami Miller School of Medicine and completed a postdoctoral fellowship at Dartmouth College Norris Cotton Cancer Center where she focused on identifying therapeutically targetable regulatory circuits in breast cancer. Lloye also holds a B.Sc. degree in Biochemistry from the University of the West Indies, Mona, in her native country of Jamaica. Her work has led to over 15 peer reviewed scientific publications and presentations at national and international conferences.
At Bristol-Myers Squib, Lloye supports development and execution of the companion/complementary biomarker diagnostic programs for BMS product development and brand teams. Prior to joining BMS, she contributed to the development of oncology immunodiagnostic and immunotherapeutic products at OncoTAb Inc., a biotech start-up and served as an Adjunct Assistant Professor at University of North Carolina in Charlotte.
In her spare time, Lloye enjoys traveling, dancing and spending time with her husband, son and extended family.
Mission statement:
There is a great need for awareness and education on dense breast tissue and the risks and challenges it poses for breast cancer diagnosis and care. This need is most evident in developing countries and I am honored for the opportunity to partner with breast cancer hub in addressing this need through research, education and by establishing collaborations around the globe.
Email: lloye.dillon@gmail.com
LinkedIn: linkedin.com/in/lloye-dillon-phd-12664833
Region(s): Jamaica, W.I./ Caribbean